Holen Sie sich die Stockscreener-App
2.70
0.75%
0.02
Handel nachbörslich:
2.71
0.010
+0.37%
Schlusskurs vom Vortag:
$2.68
Offen:
$2.68
24-Stunden-Volumen:
85,884
Relative Volume:
0.25
Marktkapitalisierung:
$64.94M
Einnahmen:
$66.58M
Nettoeinkommen (Verlust:
$-19.95M
KGV:
-2.9354
EPS:
-0.9198
Netto-Cashflow:
$-14.27M
1W Leistung:
-12.34%
1M Leistung:
-1.46%
6M Leistung:
-77.42%
1J Leistung:
-53.85%
1-Tages-Spanne:
$2.62
$2.74
1-Wochen-Bereich:
$2.62
$3.10
52-Wochen-Spanne:
$2.59
$12.23
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Compare XGN vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
2.70 | 64.46M | 66.58M | -19.95M | -14.27M | -0.9198 |
TMO
Thermo Fisher Scientific Inc
|
469.71 | 173.44B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.25 | 126.39B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
565.93 | 44.55B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.55 | 32.34B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
309.87 | 30.55B | 3.17B | 642.63M | 516.49M | 10.77 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | B. Riley Securities | Buy |
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Exagen Announces Board Resignation and Committee Restructuring - TipRanks
Ana Hooker resigns from Exagen Board; board size falls to seven - TradingView
Board reshuffle at Exagen (NASDAQ: XGN) as Ana Hooker steps down - Stock Titan
Exagen (NASDAQ: XGN) director reports 7,500 restricted stock units - Stock Titan
XGN Maintained by Canaccord Genuity -- Price Target Lowered to $8.00 - GuruFocus
Does Exagen (XGN)’s 200%+ upside potential make it one of the best penny stocks set to explode? - MSN
Exagen Inc. (NASDAQ:XGN) Short Interest Update - MarketBeat
Exagen Inc stock (US30063K1051): Is its autoimmune testing edge strong enough to unlock new upside? - AD HOC NEWS
Exagen announces resale of up to 1.15M shares - MSN
Aug Intraday: Will Exagen Inc benefit from current market trendsQuarterly Market Summary & Daily Stock Trend Reports - baoquankhu1.vn
Exagen (XGN) price target decreased by 21.78% to 10.03 - MSN
Does Exagen (XGN)’s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode? - Insider Monkey
5 Stocks Under $5 That Will Explode - Insider Monkey
BTIG Maintains Exagen (XGN) Buy Recommendation - MSN
Will Exagen Inc benefit from geopolitical trends2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
How does news flow impact Exagen (XGN) Stock | Price at $2.97, Down 1.00%Expert Breakout Alerts - Xã Thanh Hà
Is Exagen (XGN) Stock Consolidating | Price at $3.20, Up 4.58%Community Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Exagen (XGN) Price Target Increased by 12.20% to 13.41 - MSN
XGN PE Ratio & Valuation, Is XGN Overvalued - Intellectia AI
XGN Technical Analysis & Stock Price Forecast - Intellectia AI
Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
CEO Change: Is Exagen Inc benefiting from innovation trendsMarket Growth Review & Reliable Entry Point Trade Alerts - baoquankhu1.vn
How Analyst Resets Are Reshaping The Exagen (XGN) Investment Story - finance.yahoo.com
Exagen Inc stock gains spotlight ahead of Maryland MedTech Summit 2026 amid diagnostic innovation pu - AD HOC NEWS
Stop Loss: Is Exagen Incs growth already priced inGap Up & High Accuracy Trade Alerts - baoquankhu1.vn
Exagen (XGN) director lists 7,500 restricted stock units in Form 3 - Stock Titan
Exagen (XGN) CFO receives option, RSU grants and ESPP share purchase - Stock Titan
Exagen (XGN) CEO John Aballi awarded new RSUs and options - Stock Titan
Exagen prices public offering of common stock - MSN
Exagen Inc Stock (ISIN: US30063K1051) Faces Headwinds After 2025 Revenue Beat - AD HOC NEWS
Exagen Inc Stock (ISIN: US30063K1051) Faces Headwinds After 2025 Revenue Beat and Cautious 2026 Outl - AD HOC NEWS
Exagen (NASDAQ:XGN) Downgraded by Wall Street Zen to Sell - MarketBeat
Exagen Q4 Earnings Call Highlights - Defense World
Exagen Inc. 2025 Annual Report: Innovative AVISE® Autoimmune Disease Testing, Business Strategy, Pipeline, and Intellectual Property Overview - Minichart
Exagen stock price target lowered to $10 by Canaccord on margin outlook - Investing.com UK
KeyBanc cuts Exagen stock price target on pricing headwinds - Investing.com Nigeria
Exagen (XGN): Canaccord Genuity Lowers Price Target to $10.00 | - GuruFocus
Canaccord Genuity Group Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - MarketBeat
Analyst John Wilkin Lowers Price Target for Exagen (XGN) | XGN S - GuruFocus
KeyBanc cuts Exagen stock price target on pricing headwinds By Investing.com - Investing.com India
Exagen (NASDAQ:XGN) Price Target Cut to $10.00 by Analysts at Craig Hallum - MarketBeat
XGN: Keybanc Lowers Price Target to $10, Maintains Overweight Ra - GuruFocus
KeyCorp Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - MarketBeat
Exagen Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:XGN) 2026-03-11 - Seeking Alpha
Exagen stock price target lowered to $10 by Canaccord on margin outlook By Investing.com - Investing.com Canada
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):